Arkolith/Insider Trading/CYTH/Form 4

Tate Jeffrey

Chief Operating Officer, DirectorCyclo Therapeutics, Inc. (CYTH) · full profile →Form 4 · filed Apr 24, 2023
Net Buying
Open-Market Buys
$21K
Open-Market Sells
$0
Net Open-Market Flow
$21K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2023Buy(P)30K$0.71$21K62K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2023Buy(P)30K$0.13$4K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-010879) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML